Ribonucleases. Possible new approach in cancer therapy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Epigenetic regulation offers a promising avenue for cancer therapy by inhibiting protein synthesis without altering DNA.
• Ribonucleases (RNases) are enzymes with potential therapeutic applications in oncology.
• RNases from various sources exhibit distinct biological effects despite similar enzymatic mechanisms.

Purpose of the Study:

• To review the application of ribonucleases in cancer therapy.
• To explore novel strategies utilizing enzymes for cancer treatment.
• To discuss the potential of inhibitor-resistant RNases and ribozymes in targeting cancer-specific mRNA.

Main Methods:

• Review of existing literature on ribonucleases and their therapeutic potential.
• Analysis of epigenetic mechanisms in cancer therapy.
• Investigation of enzymes from novel sources like plants and fungi.
• Discussion of ribozymes and inhibitor-resistant RNases for mRNA destruction.

Main Results:

• Ribonucleases represent a promising strategy for cancer therapy through epigenetic regulation.
• Enzymes derived from plants and fungi demonstrate encouraging results in preliminary studies.
• Targeting oncogene-specific messenger RNA (mRNA) with specific RNases can induce apoptosis.

Conclusions:

• Ribonucleases offer a novel therapeutic approach for cancer by targeting protein synthesis epigenetically.
• Exploring enzymes from diverse sources, including plants and fungi, is crucial for identifying effective anti-cancer agents.
• The development of inhibitor-resistant ribonucleases and ribozymes holds significant potential for selective cancer treatment by inducing apoptosis.